| Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People | Frontiers in Pharmacology | 2022 |
| Inappropriate drug use rates of geriatric patients attending to a university hospital cardiology policlinic | Nigerian Journal of Clinical Practice | 2021 |
| Biomarkers and Optimal Management of Heart Failure in the Aging Population | | 2014 |
| A Knowledge, Attitude, and Practice Survey on Medication Safety in Korean Older Adults: An Analysis of an Ageing Society | Healthcare (Switzerland) | 2021 |
| Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients | European Journal of Clinical Pharmacology | 2021 |
| Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study | BMC Geriatrics | 2020 |
| How smart medication systems are used to support older people's drug regimens: A systematic literature review | Geriatric Nursing | 2020 |
| Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study | Neuropsychiatric Disease and Treatment | 2020 |
| The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population - Public Health Implications | Therapeutics and Clinical Risk Management | 2020 |
| The Dangers of Ignoring the Beers Criteria-The Prescribing Cascade | JAMA Internal Medicine | 2019 |
| A Comprehensive Overview of Polypharmacy in Elderly Patients in Saudi Arabia | Geriatrics (Switzerland) | 2019 |
| Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study | BMC Medicine | 2019 |
| Clinical pharmacology of old age | Expert Review of Clinical Pharmacology | 2019 |
| Ageism in Medication Use in Older Patients | International Perspectives on Aging | 2018 |
| Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by Roxithromycin | Drug Safety | 2018 |
